Stay updated on Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record now shows 'No longer looking for participants', indicating recruitment has ended, and the revision has been updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check19 days agoChange DetectedA new 'Study Status' entry was added to the history, indicating an update to how status information is presented. The release history shows an upgrade to version v3.5.5 (2026-06-04), replacing v3.5.4, reflecting a platform update to the record-keeping UI.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, representing a new version of the page’s release notes. This change updates the displayed documentation/versioning on the page.SummaryDifference0.0%

- Check62 days agoChange DetectedThis update reflects routine ClinicalTrials.gov record-history versioning, including a revision from v3.5.2 to v3.5.3 and indicating that the study record was revised around 2026-04-20/2026-04-23 for the “Study Design” and “Study Status” sections. It represents an additional submitted version of the same study record rather than a clearly substantive, user-critical change based on the provided diff.SummaryDifference0.2%

- Check69 days agoChange DetectedAdded a new Study Status entry on 2026-04-13 and updated the page revision to v3.5.2 (dated 2026-04-09). The previous revision v3.5.0 was removed on 2026-03-12.SummaryDifference0.2%

- Check98 days agoChange DetectedThe page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.